ProQR Therapeutics

$4.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (+0.75%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell PRQR and other stocks, options, and ETFs commission-free!

About PRQR

ProQR Therapeutics NV operates as a biopharmaceutical company, which engages in the discovery and development of Ribonucleic Acid RNA based therapeutics for the treatment of genetic disorders. Its initial focus is on the development of a disease-modifying therapy for the treatment of cystic fibrosis. The company was founded by Daniel de Boer, Gerard Platenburg, Henri Termeer and Dinko Valerio on February 21, 2012 and is headquartered in Leiden, the Netherlands. The listed name for PRQR is ProQR Therapeutics N.V. Ordinary Shares.

CEO
Daniel Anton de Boer
Employees
154
Headquarters
Leiden, Zuid-Holland
Founded
2012
Market Cap
203.08M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
536.54K
High Today
$4.12
Low Today
$3.97
Open Price
$4.06
Volume
124.98K
52 Week High
$10.98
52 Week Low
$3.60

Collections

PRQR Earnings

-$0.43
-$0.29
-$0.14
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
per share
Actual
-$0.30 per share

You May Also Like